FIREFLY NEUROSCIENCE, INC. business relationships
Companies named in FIREFLY NEUROSCIENCE, INC.’s 10-K filed 2026-03-31, and public companies whose annual reports name FIREFLY NEUROSCIENCE, INC.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.6 / 10
- AI naming
- <1 / 100 Top 55% in its category
- Agent readiness
- 30 / 100
- AI adoption
- 8 / 100
Named in FIREFLY NEUROSCIENCE, INC.’s annual report 1
“Neuropharmacology Biomarkers: Collaborative research with Novartis evaluated the pharmacodynamic effects of MIJ821 (onfasprodil) using our EEG analytics as an objective CNS biomarker in a Phase I first-in-human study, published in Clinical and Translational Science (2023).” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.